NCT05226533View on ClinicalTrials.gov

Clinical Trials to Assess Safety and Efficacy of DWRX2003 Combination With Remdesivir in Moderate to Severe COVID-19 Patients.

PHASE2TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

March 31, 2022

Primary Completion Date

December 16, 2022

Study Completion Date

December 21, 2022

Conditions
COVID-19
Interventions
DRUG

DWRX2003

Intramuscular injection of DWRX2003

DRUG

Placebo

Intramuscular injection of placebo

Trial Locations (3)

Unknown

RSUP Fatmawati, Jakarta

RSUPN Cipto Mangunkusumo, Jakarta

RS. Hasan Sadikin, Bandung

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY

NCT05226533 - Clinical Trials to Assess Safety and Efficacy of DWRX2003 Combination With Remdesivir in Moderate to Severe COVID-19 Patients. | Biotech Hunter | Biotech Hunter